Health Care [ 3/12 ] | Biotechnology [ 26/74 ]
NASDAQ | Common Stock
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases.
Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases and solid tumours, which is in Phase 1 clinical trials.
The company has a collaboration with autonomous therapeutics, inc. to develop novel therapies targeting metastatic tumors.
The company was formerly known as AgenTus Therapeutics, Inc. The company was incorporated in 2017 and is based in New York, New York.
MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 14, 24 | -0.05 Increased by +66.67% | -0.08 Increased by +37.50% |
| Aug 8, 24 | -0.07 Increased by +59.61% | -0.10 Increased by +27.30% |
| May 14, 24 | -0.11 Increased by +35.29% | -0.15 Increased by +26.67% |
| Mar 21, 24 | -0.16 Increased by +30.43% | -0.15 Decreased by -6.67% |
| Nov 9, 23 | -0.15 Increased by +21.05% | -0.18 Increased by +16.67% |
| Aug 10, 23 | -0.18 Increased by 0.00% | -0.20 Increased by +10.00% |
| May 11, 23 | -0.17 Increased by +26.09% | -0.24 Increased by +29.17% |
| Mar 21, 23 | -0.23 Decreased by -27.78% | -0.21 Decreased by -9.52% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | N/A Decreased by N/A% | -1.81 B Decreased by -35.21 K% | - - |
| Jun 30, 24 | 0.00 Decreased by N/A% | -2.70 M Increased by +56.40% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by -100.00% | -3.81 M Decreased by -102.35% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | -11.71 B Decreased by -532.88% | -5.46 M Increased by +27.12% | Increased by +0.05% Increased by +116.84% |
| Sep 30, 23 | 0.00 Decreased by -100.00% | -5.12 M Decreased by -11.64% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by -100.00% | -6.20 M Decreased by -37.69% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 11.71 B Increased by +N/A% | 162.54 M Increased by +2.09 K% | Increased by +1.39% Decreased by N/A% |
| Dec 31, 22 | 2.70 B Increased by +1.12 K% | -7.49 M Decreased by -29.94% | Decreased by -0.28% Increased by +89.34% |